发明名称 Pyrazolodiazepinones sedatives
摘要 Cpds. of formula (I) and their salts: - where R1 = Me or Et, R2 = C1-3 alkyl or allyl, R3 = H or Me, X1 = H, Cl, or CF3. - (I) have CNS sedative activity, as shown by their anticonvulsant effect in the anti-pentamethylene-tetrazole test (pharmacological data are given in the specification). - (II; R1 = R2 = Me, R3 = H, X1 = H) (9 g.), EtOOCCH2NH2.HCl (18 g.), piperidine (2 ml.), and pyridine (100 ml.) are stirred 30 hrs. at reflux, then evapd. to dryness under reduced pressure. - The residue is partitioned between CH2Cl2 (250 ml.) and H2O (100 ml.). The CH2Cl2 phase is separated, treated with active charcoal and Na2SO4, filtered and evapd. under reduced pressure (I; R1 = R2 = Me, R3 = X1 = H), m.p. 267 - 70 deg. (from EtOH). 2.5 g. of the base are dissolved in 15 ml. of ethanolic HCl.
申请公布号 CH517761(A) 申请公布日期 1972.01.15
申请号 CH19710015169 申请日期 1969.05.29
申请人 PARKE, DAVIS & COMPANY 发明人 ALBERT DE WALD,HORACE
分类号 C07D231/38;C07D487/04;(IPC1-7):C07D57/02 主分类号 C07D231/38
代理机构 代理人
主权项
地址